Nicolás Correa, S.A. (LON:0FDN)
9.72
+0.02 (0.21%)
At close: Nov 7, 2025
Nicolás Correa Revenue
Nicolás Correa had revenue of 58.83M EUR in the half year ending June 30, 2025, with 16.35% growth. This brings the company's revenue in the last twelve months to 119.39M, down -0.87% year-over-year. In the year 2024, Nicolás Correa had annual revenue of 121.61M with 10.59% growth.
Revenue (ttm)
119.39M EUR
Revenue Growth
-0.87%
P/S Ratio
1.01
Revenue / Employee
243.16K EUR
Employees
491
Market Cap
103.70M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 121.61M | 11.64M | 10.59% |
| Dec 31, 2023 | 109.97M | 10.91M | 11.02% |
| Dec 31, 2022 | 99.06M | 22.42M | 29.26% |
| Dec 31, 2021 | 76.63M | 10.11M | 15.20% |
| Dec 31, 2020 | 66.52M | -7.76M | -10.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |